Works matching DE "EXPOSURE Display Systems (Company)"

Vedolizumab exposure levels and clinical outcomes in ulcerative colitis: determining the potential for dose optimisation.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 4, p. 408, doi. 10.1111/apt.15113

By:

• Osterman, Mark T.;
• Rosario, Maria;
• Lasch, Karen;
• Barocas, Morris;
• Wilbur, Jayson D.;
• Dirks, Nathanael L.;
• Gastonguay, Marc R.

Publication type:

Article